Clinical Trials
3 trialsNCT03093116 2026-05-27
TRIDENT-1
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT05379985 2026-05-15
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Revolution Medicines, Inc.
Phase 1/2 Recruiting
NCT07086833 2026-05-14
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Purdue University
Phase NA Recruiting